iSERA Lifescienc

{
  "main_header": {
    "sid": 184341,
    "name": "iSERA Lifescienc",
    "stock_name": "iSERA Lifescienc",
    "full_name": "iSERA Lifesciences Ltd",
    "name_url": "stocks-analysis/isera-lifescienc",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "143.90",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "143.90",
    "mcapval": "121.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 534920,
    "symbol": "",
    "ind_name": "Miscellaneous",
    "ind_code": 67,
    "sector_id": "",
    "indexname": "India SENSEX",
    "isin": "INE899M01020",
    "curr_date": "Sep 23, 03:30 PM",
    "curr_time": "01:53 AM",
    "last_traded_at": "Sep 23, 03:30 PM IST",
    "bse_nse_vol": "1.6 k",
    "exc_status": "Active",
    "traded_date": "Sep 23, 2026",
    "traded_date_str": "2026 09 23",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/isera-lifescienc-184341-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "iSERA Lifesciences Ltd’s Stagnant Week Masks 4.97% Surge and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/isera-lifesciences-ltds-stagnant-week-masks-497-surge-and-valuation-concerns-4198879",
        "imagepath": "",
        "date": "2026-09-20 14:00:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>15 Sep:</strong> Stock steady at Rs.143.90 despite Sensex decline</p>\n                    <p><strong>16 Sep:</strong> No price change, minimal volume</p>\n                    <p><strong>17 Sep:</strong> New 52-week high at Rs.151.05 (+4.97%)</p>\n                    <p><strong>18 Sep:</strong> Sharp correction to Rs.143.90 (-4.73%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.143.90</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.143.90</div><div class=\"stat-change\">+0.00%</div></..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts iSERA Lifesciences Ltd to 52-Week High of Rs 151.05",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/isera-lifesciences-ltd-hits-new-52-week-high-at-rs15105-4196513",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/iSERALifescienc_priceRelatedfactors_4196513.png",
        "date": "2026-09-17 13:40:08",
        "description": "From a low of Rs 5.36 to a remarkable Rs 151.05, iSERA Lifesciences Ltd has surged over 2,600% in the past year, culminating in a fresh 52-week high on 17 Jun 2026. This extraordinary price momentum stands out sharply against the broader market backdrop, where the Sensex has declined by 10.12% over the same period."
      },
      {
        "title": "iSERA Lifesciences Ltd Valuation Shifts Signal Price Attractiveness Concerns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/isera-lifesciences-ltd-valuation-shifts-signal-price-attractiveness-concerns-4195456",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/iSERALifescienc_valuationdot_4195456.png",
        "date": "2026-09-17 08:00:13",
        "description": "iSERA Lifesciences Ltd has witnessed a dramatic shift in its valuation parameters, moving from a non-qualifying valuation status to being classified as very expensive. Despite this, the stock has delivered extraordinary returns year-to-date and over the past year, significantly outperforming the Sensex. This article analyses the recent valuation changes, compares them with peer averages, and assesses the implications for investors."
      },
      {
        "title": "iSERA Lifesciences Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/isera-lifesciences-ltd-is-rated-hold-4195172",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/iSERALifescienc_mojoScore_4195172.png",
        "date": "2026-09-16 10:10:03",
        "description": "iSERA Lifesciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 September 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 16 September 2026, providing investors with the most up-to-date insight into the company’s performance and outlook."
      },
      {
        "title": "iSERA Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/isera-lifesciences-ltd-is-rated-sell-4179601",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/iSERALifescienc_mojoScore_4179601.png",
        "date": "2026-09-02 10:10:04",
        "description": "iSERA Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "iSERA Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/isera-lifesciences-ltd-is-rated-sell-4163993",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/iSERALifescienc_mojoScore_4163993.png",
        "date": "2026-08-21 10:10:24",
        "description": "iSERA Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Covidh Technologies Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/covidh-technologies-ltd-is-rated-sell-4145257",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/CovidhTechnolog_mojoScore_4145257.png",
        "date": "2026-08-10 10:10:03",
        "description": "Covidh Technologies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Covidh Technologies Ltd Reports Flat Financial Trend Amid Mixed Quarterly Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/covidh-technologies-ltd-reports-flat-financial-trend-amid-mixed-quarterly-performance-4144412",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/CovidhTechnolog_fintrenddot_4144412.png",
        "date": "2026-08-10 08:00:06",
        "description": "Covidh Technologies Ltd, a micro-cap stock, has experienced a notable shift in its financial trend, moving from positive growth to a flat trajectory in the latest quarter ending June 2026. Despite a modest increase in profit after tax (PAT) over the last six months, the company’s earnings before depreciation, interest and taxes (PBDIT) and profit before tax excluding other income (PBT less OI) have deteriorated to their lowest quarterly levels, signalling challenges ahead for investors."
      },
      {
        "title": "Covidh Technologies Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/covidh-technologies-ltd-is-rated-sell-4128592",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/CovidhTechnolog_mojoScore_4128592.png",
        "date": "2026-07-30 10:10:03",
        "description": "Covidh Technologies Ltd is rated Sell by MarketsMOJO. This rating was last updated on 03 Jul 2025, but the analysis below reflects the stock’s current position as of 30 July 2026, incorporating the latest fundamentals, returns, and financial metrics available today."
      }
    ],
    "total": 335,
    "sid": "184341",
    "stock_news_url": "https://www.marketsmojo.com/news/isera-lifesciences-184341"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "07-Sep-2026",
      "details": "We hereby submit the copy of Newspaper Publication of Public Notice regarding 34th Annual General Meeting (AGM) of the Company scheduled to be held on Tuesday September 29 2026 at 3:00 P.M. (IST) through VC/ OAVM .",
      "source": "BSE"
    },
    {
      "caption": "Notice Of 34Th Annual General Meeting Of Isera Lifesciences Limited (Formerly Known As Covidh Technologies Limited) For The Financial Year 2025-26",
      "datetime": "05-Sep-2026",
      "details": "Notice of 34th Annual General Meeting (AGM) of the Company is scheduled to be held on Tuesday September 29 2026 at 3:00 P.M. (IST) through video conference (VC)/ other audio visual means (OAVM) in compliance with the applicable provisions of the Companies Act 2013 and rules made thereunder and the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) and relevant circulars issued by MCA and SEBI.",
      "source": "BSE"
    },
    {
      "caption": "Reg. 34 (1) Annual Report.",
      "datetime": "05-Sep-2026",
      "details": "we hereby submit Annual Report of Annual General Meeting of iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) for the financial year 2025-26",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "iSERA Lifesciences Ltd has declared <strong>5%</strong> dividend, ex-date: 20 Sep 13",
          "dt": "2013-09-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "iSERA Lifesciences Ltd has announced <strong>25:1</strong> rights issue, ex-date: 24 Oct 25",
          "dt": "2025-10-24",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

iSERA Lifesciences Ltd’s Stagnant Week Masks 4.97% Surge and Valuation Concerns

2026-09-20 14:00:06

Key Events This Week

15 Sep: Stock steady at Rs.143.90 despite Sensex decline

16 Sep: No price change, minimal volume

17 Sep: New 52-week high at Rs.151.05 (+4.97%)

18 Sep: Sharp correction to Rs.143.90 (-4.73%)

Week Open

Rs.143.90

Week Close

Rs.143.90

+0.00%

Read full news article

Broad-Based Technical Strength Lifts iSERA Lifesciences Ltd to 52-Week High of Rs 151.05

2026-09-17 13:40:08

From a low of Rs 5.36 to a remarkable Rs 151.05, iSERA Lifesciences Ltd has surged over 2,600% in the past year, culminating in a fresh 52-week high on 17 Jun 2026. This extraordinary price momentum stands out sharply against the broader market backdrop, where the Sensex has declined by 10.12% over the same period.

Read full news article

iSERA Lifesciences Ltd Valuation Shifts Signal Price Attractiveness Concerns

2026-09-17 08:00:13

iSERA Lifesciences Ltd has witnessed a dramatic shift in its valuation parameters, moving from a non-qualifying valuation status to being classified as very expensive. Despite this, the stock has delivered extraordinary returns year-to-date and over the past year, significantly outperforming the Sensex. This article analyses the recent valuation changes, compares them with peer averages, and assesses the implications for investors.

Read full news article

iSERA Lifesciences Ltd is Rated Hold

2026-09-16 10:10:03

iSERA Lifesciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 September 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 16 September 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

Read full news article

iSERA Lifesciences Ltd is Rated Sell

2026-09-02 10:10:04

iSERA Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

iSERA Lifesciences Ltd is Rated Sell

2026-08-21 10:10:24

iSERA Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Covidh Technologies Ltd is Rated Sell

2026-08-10 10:10:03

Covidh Technologies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Covidh Technologies Ltd Reports Flat Financial Trend Amid Mixed Quarterly Performance

2026-08-10 08:00:06

Covidh Technologies Ltd, a micro-cap stock, has experienced a notable shift in its financial trend, moving from positive growth to a flat trajectory in the latest quarter ending June 2026. Despite a modest increase in profit after tax (PAT) over the last six months, the company’s earnings before depreciation, interest and taxes (PBDIT) and profit before tax excluding other income (PBT less OI) have deteriorated to their lowest quarterly levels, signalling challenges ahead for investors.

Read full news article

Covidh Technologies Ltd is Rated Sell

2026-07-30 10:10:03

Covidh Technologies Ltd is rated Sell by MarketsMOJO. This rating was last updated on 03 Jul 2025, but the analysis below reflects the stock’s current position as of 30 July 2026, incorporating the latest fundamentals, returns, and financial metrics available today.

Read full news article

View All News